We compared the effects of intravitreal injection of bicistronic adeno-associated viral (AAV-2) vectors encoding enhanced green fluorescent protein (GFP) and either ciliary neurotrophic factor (CNTF), brain-derived neurotrophic factor (BDNF) or growth-associated protein-43 (GAP43) on adult retinal ganglion cell (RGC) survival and regeneration following (i) optic nerve (ON) crush or (ii) after ON cut and attachment of a peripheral nerve (PN). At 7 weeks after ON crush, quantification of bIII-tubulin immunostaining revealed that, compared to AAV-GFP controls, RGC survival was not enhanced by AAV-GAP43-GFP but was increased in AAV-CNTF-GFP (mean RGCs/retina: 17 4507358 s.e.m.) and AAV-BDNF-GFP injected eyes (10 20074064 RGCs/ retina). Consistent with increased RGC viability in AAV-CNTF-GFP and AAV-BDNF-GFP injected eyes, these animals possessed many bIII-tubulin-and GFP-positive fibres proximal to the ON crush. However, only in the AAV-CNTF-GFP group were regenerating RGC axons seen in distal ON (11357367 axons/nerve, 0.5 mm post-crush), some reaching the optic chiasm. RGCs were immunoreactive for CNTF and quantitative RT-PCR revealed a substantial increase in CNTF mRNA expression in retinas transduced with AAV-CNTF-GFP. The combination of AAV-CNTF-GFP transduction of RGCs with autologous PN-ON transplantation resulted in even greater RGC survival and regeneration. At 7 weeks after PN transplantation there were 27 954 (72833) surviving RGCs/retina, about 25% of the adult RGC population. Of these, 13 352 (71868) RGCs/retina were retrogradely labelled after fluorogold injections into PN grafts. In summary, AAV-mediated expression of CNTF promotes long-term survival and regeneration of injured adult RGCs, effects that are substantially enhanced by combining gene and cell-based therapies/interventions.
Introduction
After intraorbital optic nerve (ON) transection 85-90% of adult rat retinal ganglion cells (RGCs) die within 14 days. 1 The survival and regeneration of these neurons can be enhanced to some extent by intraocular injections of recombinant neurotrophic factors. For example, ciliary neurotrophic factor (CNTF) promotes RGC survival in vitro 2 and intraocular injections result in greater numbers of RGC axons regenerating into peripheral nerve (PN) segments grafted onto the cut ON. [3] [4] [5] Brain-derived neurotrophic factor (BDNF) and the related neurotrophin-4/5 (NT-4/5) also promote RGC survival following injury; [5] [6] [7] [8] [9] however, such peptides generally have a relatively short half-life in vivo and their therapeutic effects are only temporary. Repeated injections may prolong neuroprotection but will also cause greater ocular damage. Furthermore intraocular injections of neurotrophic factors do not necessarily result in substantial axonal regeneration after ON crush [6] [7] [8] 10 and may alter the expression of cognate receptors (Meyer-Franke et al.
11
, Spalding et al. 12 and see also Frank et al.
13
). More sustained expression of growth-promoting factors induced by lens injury 14, 15 or macrophage activation 16 does induce some regrowth. Increased retinal axonal growth has also been reported after cyclic AMP elevation 17 and after blockade of growth-inhibitory molecules 18, 19 or inactivation of Rho, a GTPase mediating growth cone inhibition. 20, 21 Axotomy of RGCs induces changes in expression of cell death-related genes, growth factor receptors and other molecules associated with growth. 22 One of these molecules, growth-associated protein (GAP) 43, a protein expressed by growing RGCs during development, is transiently increased after adult axotomy but greater expression is seen when injured RGCs are experimentally stimulated to regrow their axons. 23, 24 Adult transgenic mice constitutively expressing GAP43 in neurons show increased nerve sprouting following neurotrauma, suggesting GAP43 is an intrinsic presynaptic determinant for neurite outgrowth. 25, 26 Viral vectors are increasingly being used to introduce genes into cells in the mammalian visual system, resulting in the long-term, targeted supply of appropriate molecules to compromised cells. Many studies have focused on photoreceptor protection (eg Ali 27 , Surace and Auricchio 28 , Dinculescu et al. 29 ), although transduction of injured or degenerating RGCs is increasingly being reported. 19, 20, [30] [31] [32] [33] [34] [35] Most of these studies used adeno-associated viral (AAV) vectors, currently the most efficient vector for adult RGC transduction. Here, we investigate the influence of bi-cistronic AAV (serotype-2) vectors that express a modified secretable form of CNTF on axotomized adult rat RGCs. For direct comparison, we also tested AAV encoding BDNF or GAP43. Each of the transgenes encoded within the vectors was linked to green fluorescent protein (GFP) to allow visualization of transduced cells. The aim was to determine if AAVmediated delivery of these factors increased the longterm viability of axotomized adult RGCs and promoted the regeneration of their axons across an ON crush. In a novel approach, AAV-CNTF treatment was used in association with autologous PN grafted onto the cut ON. The effect of this combined gene and cell-based therapy on RGC survival and axonal regeneration was quantified.
Results bIII-tubulin immunostaining has been reported to be a reliable and simple method for identifying RGCs in retinal wholemounts derived from ON crush or PN grafted animals. 5, 16, 36 RGC counts using this approach reflect the number of cells labelled using other methods. We confirmed the validity of the bIII-tubulin immunostaining method in retinas from three normal rats that were first injected with AAV-GFP and 5 weeks later received multiple fluorogold (FG) injections into contralateral superior colliculus (SC). Virtually all rat RGCs project to contralateral SC 37 and in retinal regions with good RGC fills there was almost 100% correspondence between FG and bIII-tubulin labelling ( Figure 1a) . Consistent with previous studies, after intravitreal AAV-GFP injections the majority of transduced GFP positive ( + ) cells were located in the ganglion cell layer (GCL) (Figure 1b) . Counts from the three non-injured adult rats with FG injections in the SC revealed that most transduced cells in the GCL were RGCs but 10-15% were not FG labelled and/or bIII-tubulin + and were likely to be displaced amacrine cells (see also Malik et al.
33
, Zhou et al.
35
, Cheng et al.
38
).
Transgene expression in AAV injected eyes
To assess the effectiveness of the post-IRES GFP as a reporter gene for each of the virally-introduced constructs, 39, 40 bi-cistronic AAV-CNTF-GFP, AAV-BDNF-GFP and AAV-GAP43-GFP vectors were injected into eyes of non-injured animals containing a normal RGC population. GFP expression in retinas transduced with AAV-GFP was used for comparison. In all vector groups, 8 weeks after AAV injection GFP immunohistochemistry revealed AAV-mediated expression of this protein in many bIII-tubulin + RGCs (Figure 1c) . Moreover, in all groups occasional GFP + axons of transduced RGCs were traced along retinofugal pathways as far as the contralateral thalamus and SC. Transduction efficiency for each vector was determined only in the bIII-tubulin + , identified RGC population. After AAV-GFP injections about 25% of bIII-tubulin + RGCs were also GFP + . IRESdependent GFP expression would be expected to be lower in eyes injected with the bi-cistronic vectors. 39 Despite this, the average RGC transduction efficiency based on GFP label was relatively high in both AAV-CNTF-GFP (19.8%) and AAV-BDNF-GFP (20.6%) injected eyes, but was slightly less after AAV-GAP43-GFP injections (12.9%).
In order to interpret the data from ON crush and PN graft studies it was important to confirm long-term in vivo expression of CNTF, BDNF and GAP43 proteins, and co-localization with GFP in transduced RGCs. Again this was done in retinas from non-injured rats with an intact RGC population, using immunohistochemistry and antibodies to CNTF, BDNF or GAP43. Rats were perfused 8-11 weeks after intravitreal AAV injections. 
AAV injections and RGC viability following optic nerve crush
Using AAV there is a delay in transgene expression due to the time required for conversion of recombinant AAV-DNA to a transcriptionally active double-stranded form. 41, 42 After ocular administration there is some transgene expression after 3 days (mouse), 43 and using an antibody to GFP, we saw intense expression in some rat retinal RGCs 7 days after intravitreal injection, although the total number of transduced cells was less than that seen at 21 days. 44 After ON injury there is a 4-5 day delay before the onset of RGC death, 1 and there is a similar delay before RGC axons begin to regrow into PN grafts. 45 Based on these data we chose to inject AAV vectors into the eye 7 days prior to ON crush or PN transplantation.
The number of viable bIII-tubulin + RGCs was assessed 7 weeks after ON crush (8 weeks after intravitreal AAV injection). Retinal wholemounts and sections were also reacted with antibodies against GFP to provide an indication of the number of surviving bIII-tubulin + RGCs that were transduced by each AAV vector. Examples of transduced RGCs in wholemounts from injured animals are shown in Figure 2a there was greater variance in this group and this increase was not significant at the P ¼ 0.05 level. Examination of AAV-BDNF-GFP injected retinas suggested that this variance was, at least in part, associated with inter-eye differences in the amount of RGC (GFP + ) transduction. The maximum number of viable RGCs counted in any individual animal from these two groups was 18 355 (AAV-CNTF-GFP) and 20 657 (AAV-BDNF-GFP). GAP43 is a protein expressed by RGCs that are regenerating their axons, but it is not known to be a survival factor per se. Consistent with this, 7 weeks after ON crush there was no significant increase in the number of surviving bIII tubulin + RGCs in eyes injected with AAV-GAP43-GFP (mean ¼ 5464 RGCs/retina).
Nearest neighbour analysis
The large increase in the total number of bIII-tubulin + RGCs after intravitreal injection of bi-cistronic AAV-CNTF-GFP and AAV-BDNF-GFP was accompanied by a much smaller increase in the number of surviving bIIItubulin + RGCs that were also GFP + and thus definitively transduced (Figure 2h ). The level of post-IRES GFP expression may be low or perhaps non-detectable in some RGCs, even when using GFP immunohistochemistry to enhance sensitivity. Acknowledging this caveat, we asked whether we could detect a trophic influence of CNTF or BDNF secreted from transduced RGCs on the survival of nearby, non-GFP + RGCs. In retinal sections, we measured the distance between transduced (GFP + , bIII-tubulin + ) RGCs and the nearest surviving, bIIItubulin + , non-GFP + RGCs. For comparison the distance between neighbouring non-GFP immunolabelled RGCs was also measured. Only in AAV-BDNF-GFP injected eyes was there a trend (not significant at P ¼ 0.05) towards a nearest neighbour effect. In these retinas the mean distance between GFP + , bIII-tubulin + RGCs and 
RGC axonal regeneration into the distal optic nerve
Compared to AAV-GFP controls (Figure 3a and b), many more bIII-tubulin + fibres were observed proximal to the (Figure 3g and h). At 7 weeks post-crush, this increase in the number of axons in the ON of BDNF and CNTF groups is commensurate with the greater number of viable RGCs in the retinas of these animals ( Figure 2 ). This ON material was also stained with GFP antibodies, and while some GFP + axons were seen proximal to the crush site (arrows in Figure 3c , f and i) they were far fewer in number. GFP + axons were always co-immunostained with bIII-tubulin (examples shown in Figure 3e and f).
Only occasional bIII-tubulin + axons were observed to cross the crush site in AAV-GFP control (Figure 3a and b) and AAV-BDNF-GFP (Figure 3d and e) injected rats, sprouting no more than 20-25 mm into distal ON. In the AAV-GAP43-GFP injected group, consistent with the RGC loss seen in these animals, there were very few GFP + axons in proximal ON and no bIII-tubulin + or GFP + axons grew beyond the crush site into distal ON (not shown).
The situation was markedly different in the AAV-CNTF-GFP injected group. In these animals many bIIItubulin + axons, some of which were also GFP + , regrew across the crush site and into distal ON (Figure 3g and h). This regrowth is clearly shown in ON sections from another AAV-CNTF-GFP injected animal (Figure 4a and b). Many millimetres distal to the injury small fascicles of axons, some with abnormal axonal branching, were observed towards the middle of the ON (Figure 4c ). This abnormal branching, while rare, is further evidence for genuine regrowth rather than sparing of RGC axons. Axons were distributed across the entire width of the post-lesion ON and were confirmed to be regenerating by their immunoreactivity for GAP43 ( Figure 4d ). No GAP-43 + profiles were seen in the uninjured (right) ON. In the AAV-CNTF-GFP injected group the number of bIII-tubulin + and GAP43 + axons in the ON was quantified 0.5, 1.0 and 1.5 mm distal to the crush. There was, on average, 1136 (7367, s.e.m.) bIII-tubulin + RGC axons/ nerve at a distance of 0.5 mm distal to the ON crush, thus about 6.5% of surviving RGCs (1136/17450 Â 100) regenerated an axon beyond the injury. In the best case, 1844 axons were counted 0.5 mm distal to the crush. The number of bIII-tubulin + axons declined at greater distances (5587102 axons/nerve at 1 mm and 257795 axons/nerve at 1.5 mm). At all distances beyond the crush the number of GAP43
+ profiles was about one CNTF gene therapy and visual system repair SG Leaver et al third less, perhaps indicating downregulation of this protein in some axons 7 weeks post-injury. Occasional GAP43 + axons were traced as far as the optic chiasm but they did not appear to cross the midline (Figure 4e) . In AAV-CNTF-GFP injected rats the average maximal length of a regrown axon distal to the crush was 7.871.05 and 6.3471.3 mm in bIII-tubulin and GAP43 stained material, respectively.
AAV-CNTF expression and regeneration of RGC axons into peripheral nerve grafts
Adult RGC viability and axonal regrowth are enhanced even further by transplanting autologous PN segments onto the cut ON and we showed previously that intravitreal injections of recombinant CNTF significantly increased RGC axonal regeneration into such grafts. 3, 4 On the other hand, intraocular injections of BDNF do not promote long-distance regrowth. 5, 9, 46, 47 As substantial numbers of regrowing RGC axons were only seen distal to ON crush in AAV-CNTF-GFP injected rats, we next focused on how the novel combination of viral transduction of adult RGCs with AAV-CNTF-GFP and PN-to-ON transplantation influenced RGC survival and the longdistance regrowth of their axons.
It is difficult to quantify protein expression in the virally-transduced eye. We (Figure 1d-g ) and others (e.g. Malik et al. 33 and Liang et al. 40 ) used immunohistochemistry to show co-expression of relevant proteins and GFP in neurons in AAV injected eyes. Using an AAV bicistronic vector containing the secretable form of CNTF there is a small increase in CNTF protein (about 0.6pg/ mg soluble protein) in retinal extracts as measured by ELISA 40 ; however, we have evidence using purified CNTF gene therapy and visual system repair SG Leaver et al primary neural cells that about 80% of virally introduced, secretable CNTF is indeed secreted, 48 thus cytosolic measurements do not necessarily gauge the level of CNTF transgene expression. We therefore used quantitative RT-PCR on retinal tissue to assess the difference in the amount of CNTF mRNA in AAV-CNTF-GFP injected eyes compared to AAV-GFP and non-injected controls. At 2 weeks following AAV eye injection, compared to AAV-GFP injected and control eyes and standardized to the commonly used housekeeping gene L19, 49 there was much greater expression of CNTF mRNA in retinas from AAV-CNTF-GFP injected rats. Although only two rats were used in each group and thus statistical comparisons were not possible, normalized CNTF/L19 mRNA ratios were 0.26 and 0.1 (AAV-CNTF), 0.03 and 0.02 (AAV-GFP), and 0.01 and 0.015 (no injection), thus CNTF mRNA levels in AAV-CNTF-GFP injected eyes were already almost an order of magnitude higher just 2 weeks postinjection. The amplified CNTF sequence aligned with (rat/mouse) CNTF mRNA sequences held in GenBank.
Seven weeks following the suture of autologous PN onto the transected ON, rats injected with AAV-CNTF-GFP contained substantially more viable bIII-tubulin + RGCs than control AAV-GFP injected animals (Figure 5a and b). This increase was significant (Po0.05) compared to RGC survival in eyes injected with AAV-GFP, saline or CNTF gene therapy and visual system repair SG Leaver et al in non-injected animals ( Figure 6 ). Thus, based on a normal RGC count in Wistar rats of about 105 000, 37, 50 in AAV-CNTF-GFP injected rats over 25% of the adult RGC population remained viable 7 weeks post-axotomy. In one adult PN-grafted animal from this group 35 735 viable RGCs were counted, one third of the estimated normal RGC population.
The number of FG labelled RGCs regrowing axons into PN grafts (Figure 5c ) was also significantly greater (Po0.05) in AAV-CNTF-GFP injected eyes compared to controls ( Figure 6 ). Consistent with previous rat studies 5,51 small, medium and large RGCs were retrogradely labelled (Figure 5c ). Interestingly, transduced RGCs were not necessarily FG labelled, in fact the great majority of regenerating RGCs were not GFP + (Figure 5d ). Similarly only some of the axons in PN grafts were immunoreactive for both GFP and bIII-tubulin (Figure 5e ). Overall, in the AAV-CNTF-GFP group the maximum number of retrogradely FG labelled RGCs counted in an individual animal was 17 115, or about 16% of the normal adult RGC population ( Figure 6 ). On average nearly 50% of all surviving RGCs in AAV-CNTF-GFP injected eyes projected an axon 1-1.5 cm into the PN autograft.
Discussion
Intraocular injections of AAV vectors encoding a modified secretory form of CNTF promoted the survival of axotomized adult RGCs and stimulated the regeneration of many RGC axons across an ON crush, some growing as far as the optic chiasm. Intravitreal AAV-BDNF-GFP injections also enhanced RGC survival 7 weeks following ON crush; however although many axons were seen proximal to the injury, in these animals there was no significant regeneration into distal ON. No effect on RGC viability or regeneration was seen after transduction of retinal neurons with AAV-GAP43-GFP. In a new approach, we tested the therapeutic benefit of combining intraocular AAV gene therapy with PN transplantation. After AAV-CNTF-GFP injections and PN-ON grafts about 25% of adult RGCs remained viable at 7 weeks and about half of these cells regenerated axons 1-1.5 cm into autologous PN grafts.
RGC survival and regeneration following ON crush
Previous studies using recombinant neurotrophic factors were unable to show RGC axons regenerating a significant distance beyond an ON injury site. 3, [6] [7] [8] 10 Intraocular injection of lentiviral (LV) or adenoviral (AdV) vectors expressing CNTF transiently increased RGC survival after axotomy, [52] [53] [54] but with AdV-CNTF there was no axonal regrowth. 52 We now show that AAV mediated CNTF expression in the GCL not only increases prolonged adult RGC survival, but is sufficient to enable many axons to overcome the inhibitory nature of the injured ON. At 7 weeks after ON crush, approximately 6.5% of surviving RGCs extended bIIItubulin + axons at least 0.5 mm distal to the site of injury, and nearly 25% of these had regenerated further than 1.5 mm along the distal ON. Immunostaining with GAP43, a marker for regenerating axons, 55 confirmed this extensive regrowth in AAV-CNTF-GFP treated rats. The number of regenerating RGC axons seen in the present study is similar to the number induced to regrow after ocular macrophage activation 16 or after lens injury and AAV-mediated inactivation of RhoA. 19 After AAV-CNTF-GFP and AAV-BDNF-GFP injections the total number of surviving bIII-tubulin + RGCs far exceeded the number of GFP + RGCs. For example, after AAV-CNTF-GFP treatment only 18% of surviving RGCs were definitively transduced. IRES-dependent GFP expression might be expected to be lower in eyes injected with bi-cistronic AAV vectors, 39 nonetheless the data suggest that neurotrophic factors released by transduced RGCs facilitate the survival of neighbouring nontransduced RGCs via some form of bystander effect. 56 There is evidence that some of the trophic effects of viral vector-mediated release of CNTF on non-transduced RGCs may be via the stimulation of other neuronal and glial populations in the retina. 
CNTF gene therapy and visual system repair SG Leaver et al
Recombinant BDNF activates a number of growthassociated genes 9 and temporarily increases RGC survival.
6-8 AAV-BDNF is neuroprotective for RGCs against excitotoxicity 32 and in a rat glaucoma model. 57 We have shown that AAV-BDNF-GFP transduces RGCs and promotes their survival for at least 7 weeks after axotomy. AAV-mediated transfer of trkB to RGCs is also protective. 38 There were increased numbers of axons in ON just proximal to the ON injury, consistent with previous work showing that BDNF prevents lesioninduced die-back of RGC axons in the ON of neonatal rats. 58 However, despite this neuroprotective influence there was little effect on RGC axonal elongation beyond the crush. Similarly, intraocular injections of recombinant BDNF 7, 9, 46 or the related NT-4/5 5 do not increase RGC axonal regrowth into PN grafts. The effects of these factors may even be detrimental, most likely due to induction of local sprouting within the eye. 5, 46, 59 AAV-GAP43-GFP eye injections failed to protect axotomized RGCs. Unlike secretory neuroactive proteins, GAP43 would only affect the transduced cells themselves and the protein can only be effective if cells survive the initial insult. GAP43 has an important role in promoting neurite outgrowth 23, 24, 55 but it is not a survival factor per se, indeed prolonged over-expression of GAP43 in other CNS neurons can sometimes induce cell death. 60 
RGC survival and regeneration after combined gene therapy and PN transplantation
The combination of neuronal gene therapy and PN transplantation resulted in a substantial increase in RGC survival and axonal regeneration. At 7 weeks after axotomy and attachment of a PN segment, on average about 25% of the adult rat RGC population remained viable and about half of these neurons regenerated an axon into a PN graft. In the best case over one third of axotomized RGCs survived. These values are higher than those obtained 3 weeks 5 or one month 61 after PN-ON surgery in the presence of repeated intraocular injections of recombinant CNTF, either alone or in combination with a non-degradable cell-permeant analogue of cAMP (CPT-cAMP). These quantitative comparisons suggest that sustained AAV-mediated release of trophic factors from transduced cells is far more effective than intermittent delivery of relatively high concentrations of recombinant protein. Surprisingly, FG injections into PN grafts retrogradely labelled only 10-15% of GFP + RGCs. Given an AAV-CNTF-GFP transduction efficiency of about 20% it can be calculated that as few as 1 in 20 regenerating RGCs were unequivocally transduced with this vector, further indication of a so-called bystander effect.
CNTF acts on a receptor complex composed of an extracellular CNTF binding subunit, CNTF receptor a and two transmembrane proteins, gp130 and leukaemia inhibitory factor receptor b. 62 Via this receptor complex, CNTF activates multiple intracellular signalling pathways including the Janus kinase/signal transducer and activator of transcription (JAK/STAT) system. There are also negative regulators of cytokine signalling such as the suppressor of cytokine signalling family of proteins (SOCS). 63 We have preliminary evidence 64 that intravitreal injection of recombinant CNTF increases retinal SOCS mRNA expression for a number of days, potentially altering the long-term neurotrophic actions of the cytokine. It is not yet known whether similar changes occur after AAV-CNTF-GFP eye injections, but it is possible that high concentrations of secreted CNTF around transduced RGCs might eventually reduce their responsiveness to the cytokine.
There have been conflicting reports on the effects of AAV-CNTF on visual function in mouse retinal degeneration models. Subretinal injections of this vector increase photoreceptor viability, however, while some have reported improved function as measured by electroretinography (ERG), 65 others found that the ERG was reduced compared with controls. 66, 67 After intravitreal AAV-GFP injections only 1-2% of transduced cells are in the photoreceptor layer, 44 and immunostaining with an antibody to rhodopsin kinase (gift from Dr D Hicks), a protein found in photoreceptor outer segments, revealed no obvious differences in intensity or distribution in AAV-CNTF-GFP versus AAV-GFP injected eyes (data not shown). Our gene therapy studies are aimed at developing general strategies for CNS repair, nonetheless in future neurotrauma studies that analyse the physiology of regenerate retinofugal projections we may need to take potential non-RGC, retinal-specific effects of AAV-CNTF into account.
Conclusions
Prolonged availability of a secretable form of CNTF encoded in AAV-2 increased adult axotomized RGC survival and promoted axonal regeneration through and beyond an ON crush. AAV-BDNF-GFP also enhanced RGC survival but had no impact on regeneration. Bystander effects appeared to magnify the therapeutic impact of AAV-CNTF-GFP, thus it is not necessary to transduce every cell to obtain a large beneficial effect. RGC viability and regeneration was further enhanced by the novel combination of gene therapy and cell therapy (PN bridging grafts), modifying both the neurons themselves and the environment encountered by regrowing axons. Our results support the proposal that a multifactorial approach to neurotrauma will result in more successful and long-lasting therapeutic outcomes. 5, 20, 48, 68, 69 Materials and methods
AAV-2 vectors -structure, packaging and titering
Linear maps of the AAV-2 vector plasmids pTR-UF12. 1 70 used in this study are shown in Figure 7 . Transgenes (GFP, mouse CNTF, rat BDNF or rat GAP43) were under the control of the cytomegalovirus and chicken b-actin (CMV-CBA) hybrid promoter. 30 CNTF, BDNF and GAP43 plasmids contained IRES that enabled the bi-cistronic expression of the 'humanized' GFP reporter gene. The pTR-UF12.1-CNTF plasmid contained an NGF secretory signal sequence and thus encoded a secretable form of CNTF (gift of Dr Sendtner, University of Wurzburg). To ensure transgenes encoded within vector plasmids were translated into proteins, HEK 293T cells were transfected directly with vectors. After 24 h, cells were fixed with paraformaldehyde and immunostained with antibodies to GFP and either CNTF, BDNF or GAP43. For each bi-cistronic vector GFP was co-localized with the relevant protein in the great majority of cells. Using AAV-2 and the same CNTF construct, others have shown by Western blot and ELISA that transduced 293T cells express biologically active CNTF. 40 Cells transduced with the AAV-BDNF-GFP vector used here have been shown to release bioactive BDNF. 71 AAV viral vectors were produced and purified in accordance with methods previously described. 72 Titres (transducing units, TU) were established by transducing 293T cells with a dilution series of the purified AAV and then counting the number of GFP + cells. AAV vector stocks used in these studies were in the range of 10 9 TU/ml.
Animals
Fifty-four adult (8-to 10-week-old) female Wistar rats were used in the study. Rats were purchased from the Animal Resources Center (Western Australia) and housed under standard conditions with a 12 h light/ dark cycle. Food and water was available ad libitum throughout the experiment. Experiments conformed to Australian NHMRC guidelines and were approved by the UWA Animal Ethics Committee and the Office of the Gene Technology Regulator.
Surgery
For most surgical procedures rats were anesthetized with a 1:1 mixture of ketamine (100 mg/ml) and xylazine (20 mg/ml) (1-1.5 ml/kg. bw, i.p.). Retrograde labelling of regenerating RGCs in PN grafted animals was carried out under halothane anaesthesia (induction 5%, maintenance 2% in 1:3 ratio of O 2 to N 2 O mixture). Rats were also injected with the analgesic buprenorphine (subcut, 0.02 mg/kg, Temgesic; Reckitt & Colman, UK).
Eye injections. Using a glass micropipette, saline
was injected nasally (2 ml) and temporally (2 ml) into the vitreous of the left eye, immediately adjacent to the ora serrata and avoiding the lens (thus a total of 4 Â 10 6 TU per eye). Bilateral injections were used to facilitate transduction of RGCs across most of the retina. 44 To monitor transduction efficiency and level of GFP expression in retinas exposed to AAV-GFP and bicistronic vectors, 11 rats injected with AAV-GFP (n ¼ 3), AAV-CNTF-GFP (n ¼ 4), AAV-BDNF-GFP (n ¼ 2), or AAV-GAP43-GFP (n ¼ 2) were not operated on further but survived for 8-11 weeks before killing. Three additional rats with AAV-GFP injections but no ON surgery received FG (Fluorochrome Inc., CO, USA) injections into the right SC 5 weeks after the intraocular injections. These rats were used to quantify transduction of identified RGCs in the GCL and to confirm the use of bIII-tubulin immunostaining as an assay of RGC viability. Finally, four rats injected with AAV-GFP (n ¼ 2) or AAV-CNTF-GFP (n ¼ 2) were killed 2 weeks following injection of the viral vectors and the level of CNTF mRNA was determined by quantitative RT-PCR. Two rats that had not received any eye injections were used to control for endogenous mRNA levels.
Optic nerve crush, or optic nerve transection and PN transplantation. Following intravitreal AAV vector or saline injection, 32 rats were left for one week before they underwent ON crush surgery or PN transplantation. In 19 rats injected with AAV-GFP (n ¼ 4), AAV-CNTF-GFP (n ¼ 4), AAV-BDNF-GFP (n ¼ 6) or AAV-GAP43-GFP (n ¼ 5), under ketamine-xylazine anaesthesia the ON was exposed and crushed 1.5 mm behind the nerve head for 2 Â 10 s periods, avoiding injury to the ophthalmic artery. Animals were perfused 7 weeks following ON crush. For PN grafts, anaesthetized rats injected 7 days previously with AAV-GFP (n ¼ 4), AAV-CNTF-GFP (n ¼ 5) or saline (n ¼ 4) had the left ON exposed intraorbitally and transected about 1.5 mm behind the nerve head. A 1.5 cm segment of autologous peroneal nerve was sutured onto the proximal stump of the cut ON with 10/0 suture (Ethilon; Johnson & Johnson, Australia). The distal portion of the PN was positioned over the skull and the end sutured to connective tissue. 47 An additional four non-injected rats were used as controls for the PN-ON grafting experiments.
Retrograde labeling of RGCs
To retrogradely label regenerating RGCs, PN-grafted rats were anesthetized with halothane, the PN grafts were exposed and their distal end injected with 0.2 ml of 4% FG. Rats were perfused 3 days later, a total of 7 weeks post-transplantation. To label RGCs in retinas of non-injured rats, 5 weeks after intravitreal AAV-GFP injections rats (n ¼ 3) were anaesthetized with CNTF gene therapy and visual system repair SG Leaver et al ketamine/xylazine and the right occipital cortex overlying the SC was aspirated. Three to four injections of 4% FG (total volume 0.5-0.6 ml) were made into different parts of superficial SC. Wounds were closed and rats given an injection of buprenorphine (subcut, 0.02 mg/kg). Animals were perfused two days later.
Quantitative RT-PCR analysis
To determine the amount of CNTF mRNA present in transduced eyes, retinas from four rats that did not undergo ON injury were removed several weeks following eye injections of AAV-CNTF-GFP (n ¼ 2) or AAV-GFP (n ¼ 2). Retinas from two normal (uninjected) rats acted as further controls. CNTF mRNA levels were standardized to those of ribosomal protein L19 (housekeeping gene) by dividing by L19 mRNA levels for each cDNA sample. Compared to CNTF mRNA there was comparatively little variation in L19 expression in the different groups. 49 
Tissue processing
For perfusion, rats were deeply anaesthetized with sodium pentobarbitone (ip) and perfused with PBS (containing heparin) followed by 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Injected eyes (cornea and lens removed), ONs and brains were post-fixed in 4% paraformaldehyde for either 30 min (eyes and ONs) or 2 h (brains) before storage in 0.1 M phosphate buffer at 41C.
All retinas were first processed as wholemounts in order to survey the entire retina and determine the number of surviving RGCs and (in PN graft animals) the number of FG-labeled RGCs (see Cui et al. 5 for details). In PN grafted animals, retinas were flat-mounted, cover slipped in Citifluor and FG-labeled RGCs were counted before retinas were immunostained. The area of each retina was determined and counts were made from 60 to 80 fields (each field 0.235 Â 0.235 mm) randomly sampled across the whole retina.
bIII-tubulin and RGCs in wholemounts. Retinas from all rats were immunostained with an antibody to bIIItubulin (TUJ1 monoclonal, Covance, CA, USA) and to GFP (polyclonal, Chemicon, CA, USA). Retinas were incubated in 10% normal goat serum (NGS, Hunter Antisera, NSW, Australia) and 0.2. % Triton X-100 (Progen Industries, QLD, Australia) for 1 h, then incubated in the same medium with TUJ1 (1:1000) and GFP (1:300) antibodies for 1 day at 41C. After washes, retinas were incubated with Cy3-conjugated goat anti-mouse (Jackson ImmunoResearch Labs, PA, USA) and FITCconjugated anti-rabbit secondary antibodies (Sigma, MO, USA) overnight at 41C, washed and coverslipped in Citifluor. In retinal wholemounts from ON crush and PN grafted rats the sampling procedures used for FG counts were used to determine total numbers of GFP + cells and bIII-tubulin + RGCs.
Retinal, optic nerve and brain sections. After wholemount staining and completion of cell counts, retinas from AAV-GFP, AAV-CNTF-GFP and AAV-BDNF-GFP ON-crush animals were removed from slides and cryoprotected in a 30% sucrose solution. The ONs from all crush animals were also cryoprotected. Retinas and ONs were embedded (Jung Tissue Freezing Medium, Leica, Nussloch/Germany) and 20 mm frozen sections cut, horizontally for eyes and longitudinally for ONs. Parallel series of sections were taken, collecting every third section from eyes and every section from ONs. Sections were collected onto about 10 slides such that each slide contained a series of sections across the whole retina or ON. Frozen sections and transduced HEK 293T cells were washed in PBS and tissue was blocked for 20 min in the antibody diluent containing 5% goat serum (FCS) and 0.02% triton X-100 in PBS. Series of retinal sections were immunostained using monoclonal antibodies to bIIItubulin (1:1000, TUJ-1 Covance), rat GAP43 (1:2000, Chemicon) and/or polyclonal antibodies to GFP (1:300, Chemicon), CNTF (recognizes mouse and rat, 1:100, R&D Systems, MN, USA) or BDNF (recognizes rat and human, 1:300, Chemicon). ON sections were immunostained with antibodies to bIII tubulin, GFP and GAP43; HEK 293T cells were immunostained for GFP, CNTF, BDNF or GAP43 (dilutions as above). Sections and cells were incubated overnight at 41C in primary antibodies. After PBS washes, appropriate secondary fluorescent antibodies (Jackson ImmunoResearch Labs or Sigma) were added for 1 h at room temperature. All sectioned tissue and cell cultures were mounted in Citifluor containing Hoechst 33342 (Sigma) to label cell nuclei.
Some brains from non-operated rats that had received eye injections of AAV-GFP or bi-cistronic vectors were frozen and coronal sections (40 mm thick) collected through the diencephalon and midbrain. Endogenous peroxidase activity was blocked in 0.6% H 2 O 2 in PBS. To visualize GFP + axons in central visual areas, sections were incubated in primary antibody (GFP, 1:200) in diluent consisting of 1% bovine albumin (Sigma) and 0.2% Triton X-100 in PBS at 41C overnight. Antibody binding was visualized using a biotin-streptavidin-HRP system (Vectastain Elite ABC kit, Vector Laboratories, CA, USA) and a diamino-benzidine (DAB)-metal complex (Pierce, IL, USA). Slides were rinsed in PBS, dehydrated in alcohol, cleared in toluene and mounted in DPX (Chem-Supply, SA, Australia).
Transduction efficiency and nearest neighbour analysis
Semi-quantitative estimates of AAV transduction efficiencies were determined from retinal sections immunostained with bIII-tubulin and GFP antibodies. The total number of bIII-tubulin + RGCs and the number of doublelabelled GFP/bIII-tubulin + cells in the GCL were counted in 10-12 sections per animal (n ¼ 3 for AAV-GFP; n ¼ 2 for AAV-GAP43-GFP, AAV-CNTF-GFP and AAV-BDNF-GFP). Further analysis was undertaken to determine if there was a positive influence of AAV-CNTF-GFP and AAV-BDNF-GFP transduced RGCs on the survival of neighbouring GFP À RGCs. One slide containing a representative series of retinal sections across the whole retina was quantified for each animal. Images were captured using Image-Pro Express software (Media Cybernetics, MD, USA). All GFP + and bIII-tubulin + RGCs were counted in these sections. The distance between transduced (GFP + , bIII-tubulin + ) RGCs and the nearest surviving bIII-tubulin + , GFP À RGC was CNTF gene therapy and visual system repair SG Leaver et al measured, as was the distance between nearest neighbour, non-GFP immunolabelled RGCs.
Quantification of axonal regeneration into the distal optic nerve
Axonal growth in ON sections was quantified using a method described in detail elsewhere. 16 For each animal the numbers of bIII-tubulin + and GAP43 + axons were counted in each of four sections at 0.5, 1.0 and 1.5 mm distal to the ON crush site. The maximal distance regrown by RGC axons was also measured.
Statistical analysis
To determine whether parametric or nonparametric statistics should be used to compare the various data sets, a Levene Statistic was performed to test for homogeneity of variances. The number of surviving and transduced RGCs for each treatment were then analyzed using either a one-way ANOVA (parametric) or Kruskal Wallis H test (nonparametric). Significance levels were set at Po0.05. Mean values are given 7 the standard error of the mean (s.e.m.).
